GGrantIndex
Sort

48,018 grants matching immunotherapy

Boston Pediatric AIDS Clinical Trials Unit

$1,168,600
Children'S Hospital Boston · U01 · FY2003 · AI

Integrated analysis of HBV-specific CD4 T cell and B cell responses to define their role in chronic hepatitis B and HBV functional cure.

$1,168,511
Georg Michael Lauer · Massachusetts General Hospital · R01 · FY2024 · AI

Cancer Immunotherapy Clinical Trials

$1,168,320
Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Antibody Based Therapeuticcs for Chikungunya Virus

$1,167,991
Michael S. Diamond · Washington University · R01 · FY2014 · AI

Miami Pediatric AIDS Clinical Trials Unit

$1,167,578
University Of Miami School Of Medicine · U01 · FY2003 · AI

The Johns Hopkins Translational ImmunoEngineering (JH-TIE) BTRC

$1,167,189
Jonathan P Schneck · Johns Hopkins University · P41 · FY2022 · EB

Effects of genetic polymorphism in MHC, KIR, and related loci on human disease

$1,166,652
Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Programming T Cell Fates for Therapeutic Use

$1,166,116
Luca Gattinoni · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

cGMP manufacturing of PBI-220, a broad spectrum immunoadhesin therapeutic against

$1,166,055
Lloyd M Yu · Planet Biotechnology, Inc. · R01 · FY2012 · AI

Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence

$1,165,864
Lydie Trautmann · Oregon Health & Science University · R01 · FY2022 · MH

Primate Lentivirus Pathogenesis

$1,165,851
Malcolm Martin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

Cell Production Core Facility

$1,165,478
Robert Somerville · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA

Cell Prep Core

$1,165,478
John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA

Unlocking evolutionarily latent immune functions for treating disease

$1,165,317
Brenda L. Bass · University Of Utah · R01 · FY2023 · CA

Unlocking evolutionarily latent immune functions for treating disease

$1,165,316
Brenda L. Bass · University Of Utah · R01 · FY2024 · CA

DF/HCC Renal Cancer SPORE

$1,165,299
Michael B Atkins · Beth Israel Deaconess Medical Center · P50 · FY2008 · CA

SPORE in Cervical Cancer

$1,165,045
T.-C. Wu · Johns Hopkins University · P50 · FY2008 · CA

Tissue Processing-Sequencing Facility

$1,164,770
Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA

PEDIATRIC ACTG--ACTU

$1,164,259
Children'S Hospital Boston · U01 · FY2000 · AI

Generation of T-cell receptors recognizing antigens on non-melanoma tumors

$1,163,889
James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Immune function and the progression to type 1 diabetes

$1,163,833
University Of Florida · P01 · FY2005 · AI

Boston Pediatric AIDS Clinical Trials Unit

$1,163,520
Children'S Hospital Boston · U01 · FY2002 · AI

Pediatric Clinical Trials Program for AIDS

$1,162,490
Baylor College Of Medicine · U01 · FY2004 · AI

Pig-to-Monkey Islet Xenotransplantation

$1,161,752
Bernhard Josef Hering · University Of Minnesota · U01 · FY2017 · AI

A STINGing vaccine for TB

$1,161,477
William Ramses Bishai · Johns Hopkins University · R01 · FY2023 · AI